Keyword Search
Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building, CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago, UC= Conference Chicago at University Center
* = applied session ! = JSM meeting theme
|
Keyword Search Criteria: Clinical trial design returned 13 record(s)
|
|
Tuesday, 08/02/2016
|
A Bayesian Adaptive Clinical Trial Design: Diagnostic Accuracy of an Olfactory Diagnostic Test for Traumatic Brain Injury in Combat Soldiers
Benjamin Saville, Berry Consultants
10:35 AM
|
Detecting Treatment Differences in Group Sequential Longitudinal Studies with Covariate Adjustment
Neal Jeffries, National Heart, Lung, and Blood Institute; James Troendle, National Institutes of Health; Nancy L. Geller, National Heart, Lung, and Blood Institute
2:05 PM
|
Using Power Contours to Assess the Sensitivity of Clinical Trial Design Assumptions
Richard C. Zink, JMP Life Sciences, SAS Institute; Xiaotong Jiang, The University of North Carolina at Chapel Hill
2:35 PM
|
Hierarchical Bayesian Approaches for Clinical Trials in Orphan and Pediatric Diseases
Cynthia Basu, University of Minnesota; Freda Cooner, FDA/CDER/OTS/OB/DB2; Ram Tiwari, FDA/CDER/OT/OB; Bradley Carlin, University of Minnesota
3:05 PM
|
Practical Considerations in Clinical Trial Design
Kerry Go, Sanofi Pasteur
3:35 PM
|
|
Wednesday, 08/03/2016
|
A Clinical Trial Design Based on the Concept of Relative Time Using the Generalized Gamma Ratio Distribution
Milind Phadnis, University of Kansas Medical Center
|
A Clinical Trial Design Based on the Concept of Relative Time Using the Generalized Gamma Ratio Distribution
Milind Phadnis, University of Kansas Medical Center
9:05 AM
|
Improved Group Sequential Clinical Trial Designs with Multiple Co-Primary Endpoints
Koko Asakura, National Cerebral and Cardiovascular Center; Toshimitsu Hamasaki, National Cerebral and Cardiovascular Center; Franz Koenig, Medical University of Vienna; Martin Posch, Medical University of Vienna
9:50 AM
|
Clinical Trial Design of Authorized Biosimilars in Europe
Johanna Mielke, Novartis Pharma AG; Bernd Jilma, Medical University of Vienna; Byron Jones, Novartis Pharma; Franz Koenig, Medical University of Vienna
10:35 AM
|
|
|
